Latest Shareholder Participation News

Jindalee Lithium has pushed back the deadline for its A$2.5 million entitlement offer, giving shareholders an extra week to decide on participation. The offer includes attaching options exercisable at A$0.60, aiming to bolster the company’s capital position ahead of key development milestones.

Paradigm Biopharmaceuticals has successfully raised $21.375 million through an oversubscribed Share Purchase Plan and a recent placement, bolstering its balance sheet ahead of key Phase 3 trial milestones.

Alice Queen Limited has pushed back the closing date of its $5.77 million rights issue to 12 June 2026, giving shareholders more time to subscribe at 0.9 cents per share. The extension reflects the company's effort to maximise shareholder involvement ahead of the planned capital raise completion.

Li-FT Power Ltd. has released an extensive update to its Corporate Governance Statement, outlining its board structure, committee roles, and compliance with Canadian and ASX governance standards. The company highlights partial adherence to some ASX recommendations, reflecting its current development stage.

Beonic Ltd (ASX:BEO) has initiated a $3 million pro-rata renounceable entitlement offer at $0.08 per share, partially underwritten by Alpine Capital, to shore up working capital and repay shareholder loans. The offer carries potential dilution of 35.7% for non-participating shareholders and may increase the Thorney Group's voting power significantly.

Dicker Data has outperformed its FY25 guidance, delivering a 14.9% jump in gross revenue to $3.876 billion, fuelled by AI deals and infrastructure refreshes. The company’s FY26 outlook anticipates continued momentum in AI and data centre projects despite pricing pressures.

Strategic Elements Ltd has received $1.2 million in applications under its Share Purchase Plan, surpassing its initial $1 million target and raising the cap to $2.5 million. The extra funds will accelerate development of its moisture-powered Energy Ink™ and operational intelligence platform EdgeiQ™.

AoFrio Limited is offering existing shareholders a 1-for-7 rights issue at NZ$0.07 per share following a NZ$4.56 million placement, aiming to raise nearly NZ$5 million to fund growth ambitions.

VRX Silica’s updated 2026 Bankable Feasibility Study for Arrowsmith North confirms robust economics with an ungeared NPV8 of A$179.2 million and binding offtake contracts securing nearly 1 million tonnes annually.

Bio-Gene Technology has raised A$3.21 million to complete critical safety studies for its novel insecticide Flavocide and ramp up production of its natural insecticide Qcide, advancing its path to commercialisation in multiple global markets.

Burley Minerals Ltd is offering eligible shareholders in Australia and New Zealand the chance to buy up to $30,000 of shares at a 17.9% discount through a $300,000 Share Purchase Plan, aiming to bolster its exploration funding without brokerage costs.

WAM Strategic Value Limited updates its fully franked interim dividend details for FY2026, confirming a 3.25 cent per share payout and clarifying its Dividend Reinvestment Plan pricing and mechanics.